Pdl Biopharma Inc (PDLI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2018 | 12-2017 | 09-2017 | 06-2017 | 03-2017 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 405,078 | 527,266 | 510,085 | 349,428 | 314,327 |
| Marketable Securities | 0 | 4,848 | 6,409 | 85,895 | 94,991 |
| Receivables | 22,646 | 31,183 | 17,465 | 20,799 | 21,679 |
| Inventories | 14,012 | 9,147 | 12,216 | 11,450 | 3,533 |
| Other current assets | 55,836 | 53,613 | 57,545 | 62,361 | 103,622 |
| TOTAL | $510,944 | $640,443 | $613,230 | $536,809 | $544,019 |
| Non-Current Assets | |||||
| PPE Net | 7,557 | 7,222 | 8,130 | 9,012 | 846 |
| Intangibles | 554,877 | 565,046 | 574,043 | 571,307 | 516,328 |
| Other Non-Current Assets | 27,023 | 30,412 | 28,435 | 184,843 | 176,580 |
| TOTAL | $589,457 | $602,680 | $610,608 | $765,162 | $693,754 |
| Total Assets | $1,100,401 | $1,243,123 | $1,223,838 | $1,301,971 | $1,237,773 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 9,954 | 19,785 | 10,448 | 10,385 | 17,956 |
| Accrued Expenses | N/A | N/A | N/A | 38,108 | N/A |
| Other current liabilities | N/A | N/A | N/A | 89,000 | 88,493 |
| TOTAL | $50,963 | $193,109 | $194,132 | $276,287 | $275,250 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 206,329 | 204,124 | 206,724 | 206,886 | 199,634 |
| TOTAL | $206,329 | $204,124 | $206,724 | $206,886 | $199,587 |
| Total Liabilities | $257,292 | $397,233 | $400,856 | $483,173 | $474,837 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 150,641 | 153,812 | 154,339 | 154,081 | 160,984 |
| Common Shares | 1,528 | 1,538 | 1,543 | 1,541 | 1,637 |
| Retained earnings | 944,255 | 945,614 | 923,382 | 932,518 | 872,078 |
| Other shareholders' equity | -188 | 1,181 | 648 | 0 | 3,928 |
| TOTAL | $843,109 | $845,890 | $822,982 | $818,798 | $762,936 |
| Total Liabilities And Equity | $1,100,401 | $1,243,123 | $1,223,838 | $1,301,971 | $1,237,773 |